Scientific and Clinical Advisory Council

Scientific and Clinical Advisory Council

SafeMinds Scientific & Clinical Advisory Council is comprised of clinicians, health professionals, and scientists from a variety of disciplines, including, among others, specialists and experts in autism, environment, toxicology, pediatrics, neuroscience, pharmacology, and psychology.

José G. Dórea, Ph.D.
Professor of Nutritional Sciences, University of Brasília
A graduate of the University of Pernambuco with advanced degrees from the University of Massachusetts (MSc and PhD), Dr. Dorea has worked at Iowa State University (USA), University of Hawaii (USA), and University of Campinas (Brazil). He has authored numerous book chapters, and has published on infant nutrition and the environmental impact of toxic (natural and man made) substances on the growth and development of children. Dr. Dorea is on the editorial board of peer-reviewed scientific journals, and has authored and co-authored more than 180 papers in journals of public health, medical and environmental sciences, toxicology, and pharmacology.

Cindy Schneider, MD
Medical Director, Center for Autism Research and Education
Dr. Schneider is the Medical Director of CARE, the Center for Autism Research and Education. Her integrative medical practice is exclusively dedicated to individuals with autism and related neurological and immune disorders. Dr. Schneider’s areas of special interest include treatment of the immune, gastrointestinal, and metabolic aspects of autism and the identification of environmental toxins contributing to the autism epidemic. She has designed and implemented multiple research studies, and collaborated with researchers worldwide. Dr. Schneider’s priorities in both her medical practice and her research include the identification of the causes of autism, the formulation of effective treatment protocols, and the prevention of autism in future generations.

Dr. Schneider has served as a member of the Defeat Autism Now! think tank since 1997, and serves on the Clinician Advisory Committee at the Autism Research Institute. She was the founding president and medical director of two nonprofit organizations for autism research, and is a medical advisor for SafeMinds. Dr. Schneider has published extensively in the areas of genetic vulnerability to environmental toxins, and innovative treatments for the gastrointestinal and immune complications of autism.

As the mother of two children with autism and a leading authority in the field, Dr. Schneider closely tracks developments in autism research, and provides both a medical and personal assessment of current and promising treatment options.

Robert Sears, M.D.
Robert W. Sears, MD, FAAP, is a board-certified pediatrician in a full-time private practice in Dana Point, Calif. He received his medical degree from Georgetown University, and did his pediatric residency training at Childrens Hospital Los Angeles. “Dr. Bob,” as he likes to be called by his little patients, provides a unique blend of mainstream and integrative medical care. He is a co-author in the Sears Parenting Library, including The Baby Book and The Portable Pediatrician, and is the author of The Vaccine Book, The Autism Book, and HappyBaby: The Organic Guide to Baby’s First 24 Months. Dr. Bob has appeared on Dr. Oz, The Doctors, CNN, CBS Early Show, Fox Morning News, and Dr. Phil discussg parenting advice and pediatric health issues. He is a frequent speaker at parenting conferences, and serves on the medical advisory board for various organizations, including Talk About Curing Autism, Autism Care and Treatment Today, HappyBaby Organic Baby Food, and Kaplan University Department of Health Sciences. Dr. Bob is a contributor to AskDrSears.com, and regularly answers questions on his Mothering.com Ask the Experts forum.

March 04, 2024

Systematic Review: Mercury Exposure Contributes to the Variability in ASD Etiology

Findings Show Mercury During the Postnatal Period Is Especially Harmful A recent systematic review has underscored the role of mercury (Hg) exposure in the onset of autism spectrum disorder (ASD), particularly when such exposure occurs during the postnatal period. According to the findings, infants are highly susceptible to toxins and heavy metals like Hg during […]

February 19, 2024

New Study Demonstrates HBOT Improves Verbal Behavior in Children with ASD

Significant Advances Discovered in Requesting, Naming, Answering Questions and Social Interaction A new study has explored the effects of Hyperbaric Oxygen Therapy (HBOT) on verbal behavior in children with Autism Spectrum Disorder (ASD). A total of 65 children were included in this research, of which 32 received HBOT, and 33 served as controls. The age […]

February 12, 2024

New Research Suggests Brain Enzyme IDO2 May Be Linked to Neurological Disorders

Mice Without IDO2 Gene Exhibited Behaviors Similar to Autism New Japanese research explores how a brain enzyme called indoleamine 2,3-dioxygenase 2 (IDO2) could be related to certain complex neurological diseases, including autism spectrum disorder (ASD). The study’s design involved examining mice without the IDO2 gene to analyze how it affected their behavior. The authors found […]

February 05, 2024

Teen with Autoimmune Encephalitis Recovers Through Immunotherapy

Researchers Highlight the Importance of Distinguishing Between Autoimmune Encephalitis and ASD A recent letter to the editor published in the Journal of Clinical Neurology discusses the similarities between autoimmune encephalitis and autism spectrum disorder (ASD) in pediatric cases, emphasizing the importance of an accurate diagnosis and appropriate treatment. The authors presented a case of a […]

January 22, 2024

Maternal Use of Hormonal Contraception Up to or During Pregnancy Linked to an Increased Risk of ASD

Non-Oral Progestin-Only Birth Control Products Shown to Be Especially Problematic An extensive register-based Parental Exposures and Child Health (PECH) cohort study has discovered an increased risk of autism spectrum disorder (ASD) in children associated with maternal use of any hormonal contraception up to or during pregnancy, compared to previous use (>3 months before pregnancy start). […]

January 01, 2024

New Research Shows that Deep-Brain Stimulation Improves Cognitive Function in People with TBIs

Earlier Treatment Studies Demonstrated Improvements in Chronic Depression A small, phase 1 clinical trial has shown that deep-brain stimulation via implanted electrodes can improve cognitive function in individuals who have experienced traumatic brain injuries years or decades earlier. The current trial’s design included placing electrodes in the brains of five individuals with moderate to severe […]

Show Buttons
Hide Buttons